Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Amyotrophic Lateral Sclerosis
NCT07813858Phase 2Not yet recruiting
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Oct 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in amyotrophic lateral sclerosis (ALS), sponsored by Azienda Ospedaliera Universitaria Policlinico. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT07813858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07813858.